Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Corner wrap for use with a pallet
Systems and methods for printing images outside a normal color gamut in image forming devices
Apparatus for restoring setting information of a board management controller from a backup memory before loading an OS when a system board is replaced
Device and method for unified codes
Table base
Maintenance guidance display device, maintenance guidance display method, and maintenance guidance display program
Oral care implement accessory
  Randomly Featured Patents
Process for the production of carbonate esters
Composite structure for enhanced flexibility of electro-optic displays with sliding layers
VCR integrated with projector
Tiled embedded data block-types for generic embedded data block systems
Balance plate intelligent game apparatus
Radial bogie with steering beam mount unitized brake
Metal complex
Peelable tape carrier
Distance-measuring device of camera and focusing method of camera
Accelerated hardware emulation environment for processor-based systems